Valuation: Thyrocare Technologies Limited

Capitalization	6.54TCr 73Cr 62Cr 58Cr 55Cr 100.69Cr 109.52Cr 684.11Cr 264.15Cr 3.09TCr 272.6Cr 266.78Cr 11TCr	P/E ratio 2026 *	38x	P/E ratio 2027 *	32.9x
Enterprise value	6.54TCr 73Cr 62Cr 58Cr 55Cr 100.69Cr 109.52Cr 684.11Cr 264.15Cr 3.09TCr 272.6Cr 266.78Cr 11TCr	EV / Sales 2026 *	7.87x	EV / Sales 2027 *	6.75x
Free-Float	27.44%	Yield 2026 *	2.37%	Yield 2027 *	2.92%

More valuation ratios * Estimated data

Chart: Thyrocare Technologies Limited

Timeframe

Style

Dynamic Chart

Latest news: Thyrocare Technologies Limited

24/10	Promoter Docon Technologies sold 5.3 million shares in Thyrocare Technologies via bulk deal	RE
17/10	Thyrocare Technologies Limited, Q2 2026 Earnings Call, Oct 14, 2025
14/10	Thyrocare Technologies Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025	CI
14/10	Thyrocare Technologies board approves bonus shares issuance in 2:1 ratio	RE
14/10	Thyrocare Technologies Limited Declares an Interim Dividend	CI
23/07	Thyrocare Technologies Limited Reports Earnings Results for the First Quarter Ended June 30, 2025	CI
23/07	Thyrocare Technologies Limited, Q1 2026 Earnings Call, Jul 23, 2025
23/07	Thyrocare Technologies Limited Announces Management Changes	CI
23/07	Thyrocare Technologies Limited Announces Chief Financial Officer Changes	CI
23/07	Thyrocare Technologies appoints Vikram Gupta as CFO	RE
23/04	Thyrocare Technologies Limited, Q4 2025 Earnings Call, Apr 23, 2025
23/04	Thyrocare Technologies Limited Recommends Final Dividend for the Financial Year 2024-25	CI
23/04	Thyrocare Technologies March-Quarter Consol Net Profit 217 Mln Rupees	RE

More news

Last Transcript: Thyrocare Technologies Limited

Thyrocare Technologies Limited, Q2 2026 Earnings Call, Oct 14, 2025

14/10

More transcripts

Managers and Directors: Thyrocare Technologies Limited

Manager	Title	Age	Since
Rahul Franklin Guha CEO	Chief Executive Officer	-	04/05/2022
Brijesh Kumar CMP	Compliance Officer	-	31/01/2025

Director	Title	Age	Since
Indumathi Gopinathan BRD	Director/Board Member	-	12/08/2017
Dharmil Nirupam Sheth BRD	Director/Board Member	37	01/09/2021
Rahul Franklin Guha BRD	Director/Board Member	-	04/05/2022

More insiders

Medical & Diagnostic Laboratories

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi.($)
THYROCARE TECHNOLOGIES LIMITED	-4.24%	-17.28%	-	-	73Cr
NATERA, INC.	+1.03%	+2.40%	+44.69%	+505.47%	3.38TCr
SONIC HEALTHCARE LIMITED	+0.26%	-0.94%	-19.84%	-27.76%	757.47Cr
RADNET, INC.	-3.07%	-5.07%	-0.72%	+273.35%	606.29Cr
GENEDX HOLDINGS CORP.	-1.85%	-4.79%	+101.60%	+1,156.38%	459.47Cr
DR. LAL PATHLABS LIMITED	-0.80%	-0.73%	+1.48%	+21.51%	281.26Cr
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.	+0.67%	-2.78%	-13.70%	-59.31%	188.19Cr
FLEURY S.A.	+0.77%	-9.72%	+9.86%	-11.60%	145.91Cr
NEOGENOMICS, INC.	-2.22%	-1.65%	-30.77%	+0.85%	153.97Cr
DIAN DIAGNOSTICS GROUP CO.,LTD.	+1.40%	-3.97%	+20.17%	-40.73%	131.82Cr
Average	-0.80%	-2.75%	+12.53%	+202.02%	677.72Cr
Weighted average by Cap.	+0.08%	-0.07%	+29.39%	+388.56%

See all sector performances

Thyrocare Technologies Limited is an India-based company, which operates as a healthcare services provider. It conducts an array of medical diagnostic tests and profiles of tests that are focused on early detection and management of health disorders and diseases. Its segments include diagnostic testing services, imaging services, and others. The Diagnostic Testing Services segment includes diagnostic and testing services, selling of consumables used for collection and promotion of pathology. The Imaging Services includes diagnostic and imaging services, selling of radiopharmaceuticals, selling of consumables for reporting. The Others segment includes the sale of testing equipment and consumables, and selling of glucometer and glucostrips under the brand, Sugarscan. It has a centralized fully automated diagnostic testing laboratory, regional processing laboratories, a medical cyclotron facility and PET-CT facilities across India. It is also focused on offering pathological services.

Employees

1,822

Sector

Healthcare Facilities & Services

Calendar

30/01 - Q3 2026 Earnings Release (Projected)

More about the company

Quotes

Date	Price	Change	Volume
05/25/05	410.05 ₹	-4.24%	7,71,337
04/25/04	428.20 ₹	-1.21%	10,10,041
03/25/03	433.45 ₹	-6.62%	13,34,028
02/25/02	464.20 ₹	-4.29%	8,91,156
01/25/01	485.00 ₹	-2.16%	2,92,805

Delayed Quote NSE India S.E., December 05, 2025 at 05:19 pm IST

More quotes

Income Statement and Estimates

More financial data

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

410.70INR

Average target price

506.67INR

Spread / Average Target

+23.37%

Consensus

EPS Estimates

Revisions to estimates

Quarterly revenue - Rate of surprise

Company calendar

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

United-States

Canada

Market Closed - NSE India S.E. Other stock markets 05:19:47 05/12/2025 pm IST			5-day change	1st Jan Change
410.05 ^INR	-4.24%		-17.28%	+34.91%

1 day	-4.24%
1 week	-17.28%
Current month	-17.28%
1 month	-9.31%
3 months	-7.29%
6 months	+23.42%
Current year	+34.91%

1 week	408.1	492
1 month	408.1	536.67
Current year	219.33	536.67
1 year	219.33	536.67
3 years	138.47	536.67
5 years	138.47	536.67
10 years	135.72	536.67

	2026 *	2027 *
Net sales	830.75Cr 9.23Cr 7.93Cr 7.43Cr 6.93Cr 13Cr 14Cr 87Cr 34Cr 392.36Cr 35Cr 34Cr 1.43TCr	968.95Cr 11Cr 9.25Cr 8.67Cr 8.08Cr 15Cr 16Cr 101.41Cr 39Cr 457.63Cr 40Cr 40Cr 1.67TCr
Net income	163.9Cr 1.82Cr 1.57Cr 1.47Cr 1.37Cr 2.52Cr 2.75Cr 17Cr 6.62Cr 77Cr 6.84Cr 6.69Cr 283.04Cr	198.7Cr 2.21Cr 1.9Cr 1.78Cr 1.66Cr 3.06Cr 3.33Cr 21Cr 8.03Cr 94Cr 8.29Cr 8.11Cr 343.13Cr
Net Debt	-	-

Thyrocare Technologies Limited Share Price NSE India S.E.

Equities

THYROCARE

INE594H01019